Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0240066 (
iron deficiency
)
7,156
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Objective:
Iron deficiency anemia (IDA) is a well-known cause of secondary restless legs syndrome (RLS). Iron deficiency without anemia (IDNA) is insidious, and its association with RLS is less evaluated. We investigate prevalence and features of IDNA in a consecutive cohort of patients with RLS.
Methods:
We included sequential primary RLS patients and RLS patients with IDA. We also recruited age- and gender-matched healthy controls. RLS mimics and other comorbidities were carefully excluded.
Results:
One-hundred and ninety-six RLS patients without anemia, 26 RLS patients with IDA, and 63 controls were included. 42.3% of RLS patients without anemia had
iron deficiency
. Women were much more susceptible for IDNA with a relative risk of 5.51 (
p
< 0.0001). Women with IDNA and RLS had younger age both at interview and at RLS onset compared to women with RLS without
iron deficiency
(
NID
) (
P
< 0.01). IDNA RLS patients showed a tendency to higher risk of severe/very severe tiredness or sleepiness during the day as compared to
NID
RLS patients. Furthermore, IDNA RLS patients had longer duration of RLS (
P
< 0.01 in men,
P
< 0.05 in women) and younger age at onset (only in men,
P
< 0.05) compared to IDA RLS patients.
Conclusion:
IDNA is frequent in RLS and
iron deficiency
may be severe despite a normal hemoglobin level. Women are at much higher risk for IDNA, and IDNA in women presents some specific clinical features. Features of IDNA RLS are different from IDA RLS. Regular screening of peripheral iron parameters even in patients with normal blood counts is recommended for timely optimal management.
...
PMID:Correlates of Nonanemic Iron Deficiency in Restless Legs Syndrome. 3242 74